Envoy Medical (COCH) Long-Term Investments (2021 - 2023)

Envoy Medical has disclosed Long-Term Investments across 3 years of filings, most recently posting $44.6 million for Q2 2023.

• Long-Term Investments for Q2 2023 came in at $44.6 million, down 89.51% year-over-year; the trailing twelve-month figure through Jun 2023 was $44.6 million (down 89.51% YoY), and the FY2022 annual result was $353731.0, down 99.92% from the prior year.
• Long-Term Investments came in at $44.6 million for Q2 2023 at Envoy Medical, up from $44.4 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $427.1 million in Q3 2022 to a low of $353731.0 in Q4 2022.
• The 3-year median for Long-Term Investments is $425.0 million (2021), against an average of $306.2 million.
• Peak annual rise in Long-Term Investments reached 1.21% in 2022, while the deepest fall reached 99.92% in 2022.
• Envoy Medical's Long-Term Investments stood at $425.0 million in 2021, then tumbled by 99.92% to $353731.0 in 2022, then surged by 12521.29% to $44.6 million in 2023.
• The last three Long-Term Investments figures came in at $44.6 million (Q2 2023), $44.4 million (Q1 2023), and $353731.0 (Q4 2022), per Business Quant data.